Monocyte chemoattractant protein-1 and coronary artery disease

Clinical Cardiology

Volumn 25, Issue 4, 2002, Pages 143-147

  Ikeda, Uichi ^a   Matsui, Keiji ^a   Murakami, Yoshiaki ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute coronary syndrome; Cytokine; Inflammation; Restenosis

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANGIOGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; HUMAN; MACROPHAGE; MONOCYTE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESTENOSIS; REVIEW; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS;

EID: 0036202022     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960250403     Document Type: Review

References (47)

1. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
2. Suppressive role of endogenous endothelial monocyte chemoattractant protein-1 on monocyte transendothelial migration in vitro
3. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells
4. Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro
5. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
6. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
7. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 in endothelial cells leading to enhanced monocyte chemotaxis
8. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium
9. Activated platelets induce secretion of interleukin-1 beta, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 alpha and surface expression of intercellular adhesion molecule-1 on cultured endothelial cells
10. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice
11. Monocyte chemoattractant protein-1 but not tumor necrosis factor-alpha is correlated with monocyte infiltration in mouse lipid lesions
12. Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits
13. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein
14. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein-deficient mice
15. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis
16. Expression of monocyte chemoattractant protein-1 in vascular tissue
17. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
18. Monocyte chemoattractant protein-1 in human atheromatous plaques
19. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody
20. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium
21. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart
22. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction
23. Activation of monocytes, T-lymphocytes and plasma inflammatory markers in angina patients
24. Interaction between chemokines and oxidative stress: Possible pathogenic role in acute coronary syndromes
25. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes
26. Increased levels of monocyte-related cytokines in patients with unstable angina
27. Unstable angina. A classification
28. Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes
29. Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages
30. Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty
31. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty
32. Chronic rejection in experimental cardiac transplantation: Studies in the Lewis-F344 model
33. Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia
34. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy
35. Possible role of proinflammatory cytokines in heart allograft coronary artery disease
36. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries
37. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: Blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis
38. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice
39. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells
40. Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae
41. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
42. Inhibition of monocyte chemotactic protein-1 synthesis by statins
43. Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells
44. Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines
45. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
46. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion
47. Expression of CCR2 by endothelial cells: Implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium